Paweena Kaewman

Dr. Paweena Kaewman

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
PKPaweena Kaewman
Paweena Kaewman
SNSutisa Nudmamud-Thanoi
Sutisa Nudmamud-Thanoi
PAPatcharada Amatyakul
Patcharada Amatyakul
STSamur Thanoi
Samur Thanoi
Objective: This study investigated the mRNA expression of gamma-aminobutyric acid (GABA) receptors in the sperm of oligoasthenoteratozoospermic (OAT) and teratozoospermic (TER) men compared to normozoospermic (NOR) men, as well as the relationships between GABA receptor expression and sperm parameters, fertilization rate, and embryo quality.Methods: The mRNA expression of GABA A-α1 and GABA B-R2 receptors in sperm was examined using reverse transcription–polymerase chain reaction in three groups of patients: NOR (n=32), OAT (n=22), and TER (n=45). The fertilization rate and embryo quality were assessed in 35 patients undergoing Intracytoplasmic sperm injection (ICSI; 10 NOR, 10 OAT, and 15 TER men). Results: OAT men had significantly higher mRNA expression of GABA A-α1 and GABA B-R2 receptors in sperm than NOR men; however, the difference between TER and NOR men was not significant. High levels of these receptors were significantly correlated with low sperm concentration, motility, and morphology, as well as the rate of good-quality embryos (GQE) at the cleavage stage after ICSI. Patients whose female partners had a >50% GQE rate at the cleavage stage had significantly lower levels of GABA A-α1 receptor expression than those whose partners had a ≤50% GQE rate.Conclusion: Our findings indicate that mRNA levels of GABA receptors in human sperm are correlated with poor sperm quality and associated with embryo development after ICSI treatment. The GABA A-α1 receptor in sperm has a stronger relationship with embryo quality at the cleavage stage than the GABA B-R2 receptor.

1 January 2025 in Scientifica
Verified
Journal Article
Open access
CPChuchard Punsawad
Chuchard Punsawad
PKPaweena Kaewman
Paweena Kaewman
TTTachpon Techarang
Tachpon Techarang
DSDiana Sketriene
Diana Sketriene
LLLaddawan Lalert
Laddawan Lalert
Aging increases the risk of neurodegenerative diseases such as Parkinson’s and Alzheimer’s (PD and AD) which are potentially linked to increased oxidative stress and inflammation. Paracetamol (APAP) is known for its antioxidant and anti‐inflammatory properties; however, its potential neuroprotective effects against age‐related oxidative stress and neuroinflammation remain inadequately investigated. Therefore, we aimed to examine whether low‐dose APAP could mitigate oxidative stress and neuroinflammation in a D‐galactose (D‐gal)‐induced aging model. In our study, fifty adult male ICR mice were divided into five groups ( n = 10). Except for the normal control group, all mice received D‐gal subcutaneous injections (200 mg/kg) and were fed vehicle, 15 or 50 mg/kg APAP, or 100 mg/kg vitamin E daily for six weeks. After treatment, liver function was assessed by serum liver enzyme analysis. The liver and brain pathologies were examined using hematoxylin and eosin staining. Brain oxidative stress was evaluated through malondialdehyde (MDA) measurement. Additionally, immunohistochemistry was used to determine levels of inflammatory cytokines (TNF‐α, IL‐1β, TGF‐β, and IL‐10) and the oxidative stress marker, NADPH Oxidase 4 (NOX4). The study found no significant changes in serum liver enzymes or liver morphology among the experimental groups. However, the D‐gal group exhibited increased neuronal cell loss, along with elevated levels of MDA and NOX4 in the frontal cortex and hippocampus. Moreover, D‐gal mice showed elevated levels of TNF‐α, IL‐1β, and TGF‐β, accompanied by decreased IL‐10 levels. Notably, treatment with low‐dose APAP and vitamin E mitigated neuronal cell loss, decreased MDA levels, and attenuated NOX4 expression induced by D‐gal injection. Furthermore, low‐dose APAP, particularly at 50 mg/kg, and vitamin E reversed the alterations in TNF‐α, IL‐1β, and IL‐10 induced by D‐gal, while TGF‐β was unaffected. We suggest that low‐dose APAP exerts antioxidant and anti‐inflammatory activities to protect against neurodegeneration in a mouse model of brain aging induced by chronic D‐gal injection.

24 June 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PRPhichsinee Rerkshanandana
Phichsinee Rerkshanandana
SNSutisa Nudmamud-Thanoi
Sutisa Nudmamud-Thanoi
KPKalyarut Phumlek
Kalyarut Phumlek
PTPailada Tiemtad
Pailada Tiemtad
PTPrapapan Temkitthawon
Prapapan Temkitthawon
KIKornkanok Ingkaninan
Kornkanok Ingkaninan
Background/Objectives: Chronic stress contributes to anxiety disorders and cognitive impairment, while effective multi-target therapeutic strategies remain limited. This study investigated the effects of a standardized extract prepared from the aerial parts of Bacopa monnieri (L.) Wettst. (Brahmi) extract and an anthocyanin-rich mixed Thai berry extract, administered individually and in combination, in a chronic unpredictable mild stress (CUMS) rat model. Methods: Extracts derived from Morus alba L. (mulberry), Antidesma ghaesembilla Gaertn. (mamao), and Syzygium nervosum DC. (ma-kiang) were characterized for anthocyanin and phenolic contents, antioxidant activities, and cyanidin-3-O-glucoside levels using HPLC. Male Sprague Dawley rats were subjected to a 14-day CUMS protocol and treated with Brahmi extract, mixed Thai berry extract, or their combinations. Behavioral assessments included the open-field test, elevated plus maze, and novel object recognition test. Histopathological evaluation of the prefrontal cortex and hippocampus was also performed. Results: Brahmi extract and mixed Thai berry extract attenuated selected anxiety-related behaviors and improved recognition memory-related parameters in CUMS-exposed rats. The low-dose berry extract produced the most consistent behavioral improvements, whereas combination-treated groups showed greater histological preservation. Histopathological analysis revealed reduced neuronal degeneration and improved tissue organization in the prefrontal cortex and hippocampus of treated animals. Conclusions: These findings support the potential therapeutic relevance of Bacopa monnieri and anthocyanin-rich Thai berry extracts under chronic stress conditions, with differential effects observed between individual and combination treatments.

Verified
Journal Article
Open access
PDF file
SKSiripaporn Kesyou
Siripaporn Kesyou
WTWaree Tiyaboonchai
Waree Tiyaboonchai
JRJureepon Roboon
Jureepon Roboon
PKPaweena Kaewman
Paweena Kaewman
SCSawanya Charoenlappanit
Sawanya Charoenlappanit
SNSutisa Nudmamud-Thanoi
Sutisa Nudmamud-Thanoi
Depression is associated with dysfunction of the hypothalamic–pituitary–adrenal axis, neurotransmitter imbalance, and calcium signaling deficits. Although gamma-oryzanol (GO) has shown antidepressant effects, its underlying molecular mechanism remains elusive, while its poor aqueous solubility limits its nutraceutical application. To overcome this obstacle, we successfully developed GO solid dispersion (GOSD) with enhanced water solubility for nutraceutical formulations. This study examined the antidepressant effect of GOSD in dexamethasone (Dx)-induced depressive-like behaviors in rats using behavioral tests, including the sucrose preference test and forced-swimming test (FST). The Dx group showed a reduction in sucrose consumption and mobility time in the FST compared with controls, both of which improved following GOSD administration. Proteomics revealed changes associated with the calcium signaling pathway. Calbindin (Calb1) expression was reduced in the Dx group, whereas GOSD administration restored Calb1 levels. Given the role of Calb1, a calcium-binding protein (CBP) involved in intracellular calcium buffering, reduced Calb1 expression in the Dx group may contribute to calcium signaling dysregulation. In contrast, GOSD can attenuate Calb1 levels, which potentially contribute to its antidepressant effects. These findings suggest that the antidepressant-like effects of GOSD may involve modulation of calcium homeostasis, supporting its potential as a complementary intervention for Dx-induced depressive-like behaviors.